Back to Skandinaviska Enskilda Banken AB (publ) Skandinaviska Enskilda Banken AB (publ)

LLYLLY

Showing 7 of 30 quarters

Position history for Skandinaviska Enskilda Banken AB (publ)Skandinaviska Enskilda Banken AB (publ)'s holdings in Eli Lilly and Company

No. Skandinaviska Enskilda Banken AB (publ) exited its LLY (Eli Lilly) position in Q1 2026. Its Q4 2025 13F listed 347,671 shares worth $373.7M. Skandinaviska Enskilda Banken AB (publ) already held LLY in its Q4 2018 13F, the earliest on record, and held it in 29 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$294M

Total Shares Change

-331,877

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$916.88
0
2025-Q4
Decreased
347,671
-3.2%
$373.7M1.5%$1,069.51
0
2025-Q3
Increased
359,142
+9.2%
$274M1.1%$758.22
53
2025-Q2
Increased
329,014
+2.4%
$256.5M1.1%$772.95
50
2025-Q1
Decreased
321,385
-4.5%
$265.4M1.3%$817.26
0
2024-Q4
Increased
336,599
+1.4%
$260.5M1.2%$762.60
49
2024-Q3
Decreased
331,877
-0.7%
$294M1.4%$873.71
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used